Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Hertz Global Holdings Inc

Start price
Target price
Perf. (%)
€1.10
-
-

Risky Investment
High challenges to pay loans and raise capital
High risks for its business
Snowflake Inc.

Start price
Target price
Perf. (%)
€201.40
€120.00
-

Revenue growth >5% per year expected
Capable Management
Probably not worthwhile Investment
overvalued
Airbus Group SE

Start price
Target price
Perf. (%)
€68.90
-
-

Well known brand
Differentiated customer and product portfolio
Innovative
Higher risks for its business
Nielsen Holdings

Start price
Target price
Perf. (%)
€13.00
-
-

High dividend yield expected
Differentiated customer and product portfolio
Revenue decline/stagnation expected
Little innovation
Novavax Inc.

Start price
Target price
Perf. (%)
€91.37
-
-

Could be worthwhile Investment >10% per year
Little known brand
Curevac N.V.

Start price
Target price
Perf. (%)
€44.02
-
-

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Little known brand
Alphabet Inc. C

Start price
Target price
Perf. (%)
€1,231.2
-
-

Could be worthwhile Investment >10% per year
Rocket Internet AG

Start price
Target price
Perf. (%)
€18.66
-
-

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.35
-
-

Risky Investment
Snowflake Inc.

Start price
Target price
Perf. (%)
€201.40
-
-

Risky Investment
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€148.58
-
-

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Market Leader or Top 3
Small cyclical dependencies
Apple Inc.

Start price
Target price
Perf. (%)
€90.16
-
-

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Grenke AG

Start price
Target price
Perf. (%)
€34.00
-
-

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.35
-
-

Could be very worthwhile Investment >20% year
Quantafuel As

Start price
Target price
Perf. (%)
€6.86
-
-

Could be very worthwhile Investment >20% year
ConAgra Foods Inc.

Start price
Target price
Perf. (%)
€29.48
-
-

EBIT growth >5% per year expected
Revenue growth >5% per year expected
High dividend yield expected
Nikola Corp.

Start price
Target price
Perf. (%)
€29.00
€20.00
-

Could be worthwhile Investment >10% per year
Well known brand
Very Future proof/growth oriented business model
Wirecard AG

Start price
Target price
Perf. (%)
€0.87
€1.15
-8.572%

Very high cyclical dependencies
Risky Investment
Verbio Ver.bioenergie

Start price
Target price
Perf. (%)
€16.98
€22.00
2.238%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Grenke AG

Start price
Target price
Perf. (%)
€33.98
-
0.059%

thyssenkrupp AG ADR

Start price
Target price
Perf. (%)
€5.60
-
4.464%

Top 10 in its market
Probably not worthwhile Investment
Significant cyclical dependencies
Business model of the past or high risk
Medigene AG

Start price
Target price
Perf. (%)
€4.63
€6.00
-1.405%

Could be worthwhile Investment >10% per year
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.20
€12.00
-3.571%

Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€6.70
€8.00
2.239%

Could be worthwhile Investment >10% per year
Cutera Inc.

Start price
Target price
Perf. (%)
€16.40
€18.00
6.098%

Could be worthwhile Investment >10% per year